[ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. I. SIDE-EFFECTS AND RISKS OF POTENTIATION].
D000928:Antidepressive Agents; D002319:Cardiovascular System; D002490:Central Nervous System; D002543:Cerebral Hemorrhage; D002965:Classification; D003863:Depression; D003866:Depressive Disorder; D004357:Drug Synergism; D004358:Drug Therapy; D006973:Hypertension; D008107:Liver Diseases; D008995:Monoamine Oxidase; D008996:Monoamine Oxidase Inhibitors; D010600:Pharmacology; D014116:Toxicology
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D008995:Monoamine Oxidase
ANTIDEPRESSIVE AGENTS; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CEREBRAL HEMORRHAGE; CLASSIFICATION; DEPRESSION; DRUG SYNERGISM; DRUG THERAPY; HYPERTENSION; LIVER DISEASES; MONOAMINE OXIDASE INHIBITORS; PHARMACOLOGY; REVIEW; TOXICOLOGIC REPORT
ANTIDEPRESSIV BEHANDLING MED MONOAMINOXIDAS-(MAO)-HAEMMARE. I. BIVERKNINGAR OCH POTENTIERINGSRISKER.